Literature DB >> 6406886

Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

J Avorn, S B Soumerai.   

Abstract

Improving precision and economy in the prescribing of drugs is a goal whose importance has increased with the proliferation of new and potent agents and with growing economic pressures to contain health-care costs. We implemented an office-based physician education program to reduce the excessive use of three drug groups: cerebral and peripheral vasodilators, an oral cephalosporin, and propoxyphene. A four-state sample of 435 prescribers of these drugs was identified through Medicaid records and randomly assigned to one of three groups. Physicians who were offered personal educational visits by clinical pharmacists along with a series of mailed "unadvertisements" reduced their prescribing of the target drugs by 14 per cent as compared with controls (P = 0.0001). A comparable reduction in the number of dollars reimbursed for these drugs was also seen between the two groups, resulting in substantial cost savings. No such change was seen in physicians who received mailed print materials only. The effect persisted for at least nine months after the start of the intervention, and no significant increase in the use of expensive substitute drugs was found. Academically based "detailing" may represent a useful and cost-effective way to improve the quality of drug-therapy decisions and reduce unnecessary expenditures.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406886     DOI: 10.1056/NEJM198306163082406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  181 in total

Review 1.  Prescription data as a tool in pharmacotherapy audit (I). General considerations.

Authors:  C S de Vries; T F Tromp; W Blijleven; L T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  1999-04

Review 2.  Prescription data as a tool in pharmacotherapy audit (II). The development of an instrument.

Authors:  C S de Vries; P B van den Berg; J W Timmer; A Reicher; W Blijleven; T F Tromp; L T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  1999-04

3.  Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message.

Authors:  P McGettigan; J Golden; J Fryer; R Chan; J Feely
Journal:  Br J Clin Pharmacol       Date:  2001-02       Impact factor: 4.335

4.  Changing doctor prescribing behaviour.

Authors:  P S Gill; M Mäkelä; K M Vermeulen; N Freemantle; G Ryan; C Bond; T Thorsen; F M Haaijer-Ruskamp
Journal:  Pharm World Sci       Date:  1999-08

5.  Confidential prescriber feedback and education to improve antibiotic use in primary care: a controlled trial.

Authors:  J E Hux; M P Melady; D DeBoer
Journal:  CMAJ       Date:  1999-08-24       Impact factor: 8.262

6.  Pilot study for appropriate anti-infective community therapy. Effect of a guideline-based strategy to optimize use of antibiotics.

Authors:  J Stewart; J Pilla; L Dunn
Journal:  Can Fam Physician       Date:  2000-04       Impact factor: 3.275

Review 7.  Recommendations for future studies: a systematic review of educational interventions in primary care settings.

Authors:  U Freudenstein; A Howe
Journal:  Br J Gen Pract       Date:  1999-12       Impact factor: 5.386

8.  Modification of general practitioner prescribing of antibiotics by use of a therapeutics adviser (academic detailer).

Authors:  K F Ilett; S Johnson; G Greenhill; L Mullen; J Brockis; C L Golledge; D B Reid
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

9.  A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice.

Authors:  Nick Freemantle; Irwin Nazareth; Martin Eccles; John Wood; Andrew Haines
Journal:  Br J Gen Pract       Date:  2002-04       Impact factor: 5.386

10.  Pharmaceutical cost containment with reference-based pricing: time for refinements.

Authors:  Sebastian Schneeweiss; Malcolm Maclure; Colin Dormuth; Jerry Avorn
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.